ZA80371B - Ligand analog-irreversible enzyme inhibitor conjugates and methods for use - Google Patents

Ligand analog-irreversible enzyme inhibitor conjugates and methods for use

Info

Publication number
ZA80371B
ZA80371B ZA00800371A ZA80371A ZA80371B ZA 80371 B ZA80371 B ZA 80371B ZA 00800371 A ZA00800371 A ZA 00800371A ZA 80371 A ZA80371 A ZA 80371A ZA 80371 B ZA80371 B ZA 80371B
Authority
ZA
South Africa
Prior art keywords
methods
enzyme inhibitor
ligand analog
inhibitor conjugates
irreversible enzyme
Prior art date
Application number
ZA00800371A
Other languages
English (en)
Inventor
T Herrin
H Voss
J Plattner
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of ZA80371B publication Critical patent/ZA80371B/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075—Esters with hydroxyalkyl compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA00800371A 1979-02-05 1980-01-22 Ligand analog-irreversible enzyme inhibitor conjugates and methods for use ZA80371B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/009,007 US4273866A (en) 1979-02-05 1979-02-05 Ligand analog-irreversible enzyme inhibitor conjugates and methods for use

Publications (1)

Publication Number Publication Date
ZA80371B true ZA80371B (en) 1981-03-25

Family

ID=21735028

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00800371A ZA80371B (en) 1979-02-05 1980-01-22 Ligand analog-irreversible enzyme inhibitor conjugates and methods for use

Country Status (15)

Country Link
US (1) US4273866A (fr)
JP (1) JPS55104896A (fr)
AT (1) AT365781B (fr)
AU (1) AU528592B2 (fr)
BE (1) BE881557A (fr)
CA (1) CA1137077A (fr)
CH (1) CH641569A5 (fr)
DE (1) DE3003959C2 (fr)
ES (1) ES488263A0 (fr)
FR (1) FR2447966A1 (fr)
GB (1) GB2043245B (fr)
IT (1) IT1130254B (fr)
NL (1) NL8000698A (fr)
SE (1) SE448259B (fr)
ZA (1) ZA80371B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981001414A1 (fr) * 1979-11-19 1981-05-28 Charles Hospital Dev Procede ameliore d'analyse immunologique d'enzymes non homogenes
DE3006709A1 (de) * 1980-02-22 1981-08-27 Hans A. Dipl.-Chem. Dr. 8000 München Thoma Homogenes verfahren zur kompetitiven bestimmung von liganden
US4341865A (en) * 1980-07-21 1982-07-27 Abbott Laboratories Determination of thyroxine binding globulin
US4849353A (en) * 1980-09-30 1989-07-18 Cornell Research Foundation, Inc. Immunocapture of enzyme inhibitor, enzyme complexes and uses thereof
US4323647A (en) * 1980-10-15 1982-04-06 University Of Miami Steric hindrance enzyme immunoassay
DE3100062A1 (de) * 1981-01-02 1982-08-05 Hans A. Dipl.-Chem. Dr. 8000 München Thoma Homogenes verfahren zur bestimmung von liganden
DE3100061A1 (de) * 1981-01-02 1982-08-05 Hans A. Dipl.-Chem. Dr. 8000 München Thoma Verfahren zur bestimmung von liganden mittels kompetitionsreaktion
EP0079489A1 (fr) * 1981-11-04 1983-05-25 Miles Laboratories, Inc. Iodothyronine conjuguée marquée par du méthotrexate et méthode, réactif et dispositif d'épreuve pour la détermination d'iodothyronine ou de l'absorption d'iodothyronine dans un échantillon liquide
US4451652A (en) * 1982-05-24 1984-05-29 Abbott Laboratories Substituted theophylline salts
US4472301A (en) * 1982-05-27 1984-09-18 Miles Laboratories, Inc. Propranolol immunogen and antibodies
GB2135773B (en) * 1983-01-31 1985-12-04 Boots Celltech Diagnostics Enzyme inhibitor labelled immunoassay
US4650751A (en) * 1983-04-29 1987-03-17 Technicon Instruments Corporation Protected binding assay avoiding non-specific protein interference
US4550075A (en) * 1983-06-22 1985-10-29 Kallestad Laboratories, Inc. Method for ligand determination utilizing an immunoassay monitorable by biotin-containing enzymes, and compositions therefor
JPS607362A (ja) * 1983-06-27 1985-01-16 Fujirebio Inc 酵素を用いた抗原決定基具有物質の測定法
US4629694A (en) * 1983-07-12 1986-12-16 Cornell Research Foundation, Inc. Detecting and distinguishing between plasminogen activators
US4543412A (en) * 1983-11-04 1985-09-24 Abbott Laboratories Phenobarbital enzyme inhibitors
IL73293A (en) * 1983-11-04 1988-02-29 Abbott Lab Methyl 2-(alkanamidoalkylsulfonic)ethylthiophosphonate derivatives
US4559173A (en) * 1983-11-04 1985-12-17 Abbott Laboratories N-substituted dibenz[b,f]azepine salts
DE4007048A1 (de) * 1990-03-07 1991-09-12 Hoechst Ag N-acyl-aminoalkyl-2-hydroxyethylsulfide und ein verfahren zu ihrer herstellung
US5338663A (en) * 1990-08-24 1994-08-16 President And Fellows Of Harvard College Method of identifying inhibitors of β-protein esterase activity
US5648462A (en) * 1990-10-09 1997-07-15 Setsuko Funakoshi Peptide purification method using novel linker and solid-phase ligand
JP2552049B2 (ja) * 1990-10-09 1996-11-06 舩越 節子 合成ペプチド精製方法およびこれに用いるリンカー、リンカー結合用固相担体
JPH0737982B2 (ja) * 1992-12-14 1995-04-26 元成 狩野 抗胆汁酸抗体およびこれを用いた糞便中の胆汁酸検査方法
US5922703A (en) * 1993-09-24 1999-07-13 The Procter & Gamble Company Urethane-containing aminosteroid compounds
WO1995022546A1 (fr) * 1994-02-18 1995-08-24 Cell Therapeutics, Inc. Mediateurs de signalisation intracellulaire
US6524808B1 (en) * 1999-06-25 2003-02-25 Roche Diagnostics Corporation Enzyme inhibition immunoassay
US6811998B2 (en) * 1999-06-25 2004-11-02 Roche Diagnostics Operations, Inc. Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase
ES2298146T3 (es) * 1999-06-25 2008-05-16 Roche Diagnostics Operations, Inc. Inmunoensayo de inhibicion de enzimas.
WO2003089599A2 (fr) * 2002-04-16 2003-10-30 The Regents Of The University Of California Ligand detectant l'acetylcholinesterase fluorescente pour la detection de l'activite d'organophosphates
ES2654584T3 (es) 2010-01-15 2018-02-14 Suzhou Neupharma Co., Ltd Ciertas entidades químicas, composiciones y métodos
WO2012027957A1 (fr) 2010-08-28 2012-03-08 Suzhou Neupharma Co., Ltd. Dérivés de bufaline, compositions pharmaceutiques et utilisation de ceux-ci
EP2670763B1 (fr) * 2011-02-02 2018-08-01 Suzhou Neupharma Co., Ltd Certaines entités chimiques, compositions et procédés
EP3453713B1 (fr) 2012-04-29 2021-09-08 Neupharma, Inc. Dérivés bufadiènolides substitués en position 3 par un groupement amine pour le traitement du cancer
CN112114127A (zh) * 2020-09-09 2020-12-22 武汉生之源生物科技股份有限公司 一种甘胆酸均相酶免疫测定试剂盒及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN142734B (fr) * 1975-04-28 1977-08-20 Miles Lab
NL7512939A (nl) * 1975-11-04 1977-05-06 Tno Werkwijze en inrichtingen voor het aantonen en/of bepalen van alkylerende verbindingen, zoals mosterdgassen.
US4134792A (en) 1976-12-06 1979-01-16 Miles Laboratories, Inc. Specific binding assay with an enzyme modulator as a labeling substance
GB1595101A (en) * 1977-03-15 1981-08-05 Hoffmann La Roche Enzyme modifier immunoassay
IT1105734B (it) * 1977-07-14 1985-11-04 Syva Co Prova di legame di competizione di antienzima omogeneo

Also Published As

Publication number Publication date
ES8101647A1 (es) 1980-12-16
CA1137077A (fr) 1982-12-07
SE448259B (sv) 1987-02-02
ATA56080A (de) 1981-06-15
ES488263A0 (es) 1980-12-16
SE8000843L (sv) 1980-08-06
DE3003959C2 (de) 1982-12-23
IT8019675A0 (it) 1980-02-04
CH641569A5 (fr) 1984-02-29
FR2447966B1 (fr) 1984-10-19
JPS55104896A (en) 1980-08-11
US4273866A (en) 1981-06-16
DE3003959A1 (de) 1980-08-14
BE881557A (fr) 1980-08-05
GB2043245A (en) 1980-10-01
AT365781B (de) 1982-02-10
AU528592B2 (en) 1983-05-05
GB2043245B (en) 1983-05-25
FR2447966A1 (fr) 1980-08-29
IT1130254B (it) 1986-06-11
NL8000698A (nl) 1980-08-07
AU5476380A (en) 1980-08-14

Similar Documents

Publication Publication Date Title
GB2043245B (en) Ligand analogue-irreversible enzyme inhibitor conjugates and methods for use
ZA806641B (en) Enzyme derivatives
JPS5610715A (en) Amplifier
IE781442L (en) Enzyme particles
GB2051075B (en) Plasminogen activator
JPS5684006A (en) Amplifier
GB2053612B (en) Sense amplifier
YU82683A (en) Rptary plough for holding and eaqualizing the inversion
JPS5663957A (en) Nnazidosulfonylaryllmaleinimide and its use
AU535400B2 (en) Wirebroadcast and viewphone
JPS56124651A (en) Lockerrhousing and lockerrcover
DE3049803D2 (en) Orthodynamic head-phones
JPS55154994A (en) Amtibiotic aa6888c and aa6888x
JPS55145408A (en) Preamplifier
MY8500127A (en) Analgesic and myotonolytic preparations
JPS55159014A (en) Pipe support and installaton method thereof
GB2048857B (en) -lactamase inhibitors
GB2064254B (en) Photo-feedback preamplifier
JPS566509A (en) Preamplifier
NZ193527A (en) Steroid salpha-reductase inhibitors
JPS55151852A (en) Amplifier
JPS5649732A (en) Fluorosilicone and its manufacture
JPS579777A (en) 1-epi-2-deoxyfortimicin b and derivative
ZA80273B (en) 4-phenylthioalkanesulfonanilides and derivatives thereof
GB2117375B (en) N-alkysulfonyl-and n-alkoxycarbonyl-substituted alkanesulfonanilides and derivatives thereof